ASNDAscendis Pharma

Median target
$315.5
calls from the last 12 months
Implied return
+32.0%
median target vs. price
Coverage
20 analysts · 22 calls
updated in the last 12 months
Consensus
20/0/0+20 net
Buy / Hold / Sell

Which analysts are behind ASND's consensus?

See every current rating, price target and the analysts' track records for Ascendis Pharma — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 20 analysts with calls on ASND updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ASND elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-08InsidersBodenhoff MadsSVP & PAOInsider sale3.0K sh @ $270.19$811K
2026-09-02InsidersHoltug LarsDirectorInsider sale236 sh @ $264.13$62K
2026-08-14InsidersBienaime Jean JacquesDirectorInsider purchase1.1K sh @ $245.85$270K
2026-08-14InsidersBienaime Jean JacquesDirectorInsider purchase900 sh @ $246.91$222K
2021-10-07ExecutiveRemy, DonaldDeputy SecretarySaleASCENDIS PHARMA (ASND)$1,001 - $15,000
2021-10-07ExecutiveRemy, DonaldDeputy SecretarySaleASCENDIS PHARMA (ASND)$1,001 - $15,000
2021-10-07ExecutiveRemy, DonaldDeputy SecretarySaleASCENDIS PHARMA (ASND)$1,001 - $15,000
2021-10-07ExecutiveRemy, DonaldDeputy SecretarySaleASCENDIS PHARMA (ASND)$1,001 - $15,000
2021-10-07ExecutiveRemy, DonaldDeputy SecretarySaleASCENDIS PHARMA (ASND)$1,001 - $15,000
2021-10-07ExecutiveRemy, DonaldDeputy SecretarySaleASCENDIS PHARMA (ASND)$1,001 - $15,000

More: congressional trades on ASND · insider activity · executive branch · trending